The Prevalence of Chiari II Malformation in Neonates with Myelomeningocele at Ayub Teaching Hospital, KPK


  • Ehtisham Ahmed Khan Afridi
  • Muhammad Waleed Khan
  • Shabana Naz
  • Saadia Maqbool
  • Aqsa Shehzadi
  • Nusrat Shaheen



Objective:  Neural tube defects (NTDs) are common in northern areas of Khyber Pakhtunkhwa (KPK) and need a lot of community education for the parents regarding this disease, which impaired the patients for their whole life. The study aimed to assess the contribution of a family history of myelomeningocele and the resulting incidence of Chiari II malformation.

Materials and Methods:  A total of 131 patients were observed to determine the frequency of the Chiari II malformation in patients with myelomeningocele who presented in Ayub Teaching Hospital, Abbottabad. All neonates were sent to the radiology department for MRI. A repair procedure for meningomyelocele was done.

Results:  The mean age was 16.56 days. In 53.4% of neonates, there was a familial history of spinal dysraphism, while in 46.6% there was no familial history. Chiari II malformation was present in 23.7% of patients who presented with myelomeningocele. A significant difference (p-value < 0.00001) existed between the presence/absence of a family history of myelomeningocele and Chiari II malformation out of the total.

Conclusion:  Early surgery, along with a multidisciplinary approach, provides the best opportunity for improved results and survival.

Keywords:  Meningomyelocele, Neural Tissue, Maternal Folate Intake, Meningomyelocele (MMC) Repair.


Stevenson KL. Chiari Type II malformation: past, present, and future. Neurosurg Focus, 2004 Feb. 15; 16 (2): E5.

Tubbs RS, Oakes WJ. Treatment and management of the Chiari II malformation: an evidence-based review of the literature. Childs Nerv Syst. 2004; 20 (6): 375-81.

Hidalgo JA, Varacallo M. Arnold Chiari Malformation, 2020 Jan.

Hori A. Tectocerebellar dysraphia with posterior encephalocele (Friede): report of the youngest case. Reappraisal of the condition uniting Cleland-Chiari (Arnold-Chiari) and Dandy-Walker syndromes. Clin Neuropathol. 1994; (4): 216-20.

Nagaraj UD, Bierbrauer KS, Zhang B, Peiro JL, Kline-Fath BM. Hindbrain Herniation in Chiari II Malformation on Fetal and Postnatal MRI. AJNR Am J Neuroradiol. 2017; 38 (5): 1031-1036.

Beuriat PA, Szathmari A, Rousselle C, Sabatier I, Di Rocco F, Mottolese C. Complete Reversibility of the Chiari Type II Malformation After Postnatal Repair of Myelomeningocele. World Neurosurg. 2017 Dec. 108: 62-68.

McLone DG, Knepper PA. The cause of Chiari II malformation: a unified theory. Pediatr Neurosci. 1989; 15 (1): 1-12.

Mulkey SB, Bulas DI, Vezina G, Fourzali Y, Morales A, Arroyave-Wessel M, et al. Sequential Neuroimaging of the Fetus and Newborn With In Utero Zika Virus Exposure. JAMA Pediatr. 2019; 173 (1): 52-59.

Cherny B. Barrow Neurological Institute. Myelomeningocele Repair. 2022. Available from:

Miller E, Widjaja E, Blaser S, Dennis M, Raybaud C. The old and the new: supratentorial MR findings in Chiari II malformation. Childs Nerv Syst. 2008; 24 (5): 563-75.

Goh S, Bottrell CL, Aiken AH, Dillon WP, Wu YW. Presyrinx in children with Chiari malformations. Neurology, 2008; 71 (5): 351-6.

Ando K, Ishikura R, Ogawa M, et al. MRI tight posterior fossa sign for prenatal diagnosis of Chiari type II malformation. Neuroradiology, 2007 Dec.

(12): 1033-9.

Geerdink N, van der Vliet T, Rotteveel JJ, Feuth T, Roeleveld N, Mullaart RA. Interobserver reliability and diagnostic performance of Chiari II malformation measures in MR imaging--part 2. Childs Nerv Syst. 2012; 28 (7): 987-95.

KHAN A. Outcome of Myelomeningocele Repair and Early Post-operative Complications. Pakistan Journal of Neurological Surgery, 2018; 22 (4): 200-5.

Oncel MY, Ozdemir R, Kahilogullar? G, Yurttutan S, Erdeve O, Dilmen U. The effect of surgery time on prognosis in newborns with meningomyelocele. Journal of Korean Neurosurgical Society, 2012; 51 (6): 359-62.

Rehman L, Shiekh M, Afzal A, Rizvi R. Risk factors, presentation and outcome of meningomyelocele repair. Pakistan Journal of Medical Sciences, 2020; 36 (3): 422.

Kshettry VR, Kelly ML, Rosenbaum BP, Seicean A, Hwang L, Weil RJ. Myelomeningocele: surgical trends and predictors of outcome in the United States, 1988–2010. Journal of Neurosurgery: Pediatrics, 2014; 13 (6): 666-78.

Shim JH, Hwang NH, Yoon ES, Dhong ES, Kim DW, Kim SD. Closure of myelomeningocele defects using a Limberg flap or direct repair. Archives of Plastic Surgery, 2016; 43 (01): 26-31.

Dupepe EB, Hopson B, Johnston JM, Rozzelle CJ, Oakes WJ, Blount JP, Rocque BG. Rate of shunt revision as a function of age in patients with shunted hydrocephalus due to myelomeningocele. Neurosurgical Focus, 2016; 41 (5): E6.

Pinto FC, Matushita H, Furlan AL, Alho EJ, Goldenberg DC, Bunduki V, Krebs VL, Teixeira MJ. Surgical treatment of myelomeningocele carried out at ‘time zero’ immediately after birth. Pediatric Neurosurgery, 2009; 45 (2): 114-8.

Wilberger JE Jr, Maroon JC, Prostko ER, et al. Magnetic resonance imaging and intraoperative neurosonography in syringomyelia. Neurosurgery, 1987; 20 (4): 599- 605.

Sattar TS, Bannister CM, Russell SA, Rimmer S. Pre-natal diagnosis of occult spinal dysraphism by ultrasonography and post-natal evaluation by MR scanning. Eur J Pediatr Surg. 1998; 1: 31-3.

Piper RJ, Pike M, Harrington R, Magdum SA. Chiari malformations: principles of diagnosis and

management. BMJ. 2019; 365: l1159.

Herweh C, Akbar M, Wengenroth M, Blatow M, Mair-Walther J, Rehbein N, et al. DTI of commissural fibers in patients with Chiari II-malformation. Neuroimage, 2009; 44 (2): 306-11.

Woitek R, Prayer D, Weber M, Amann G, Seidl R, Bettelheim D, Schöpf V, Brugger PC, Furtner J, Asenbaum U, Kasprian G. Fetal diffusion tensor quantification of brainstem pathology in Chiari II malformation. European Radiology, 2016; 26 (5): 1274-83.

Werner H, Lopes J, Tonni G, Araujo Júnior E. Physical model from 3D ultrasound and magnetic resonance imaging scan data reconstruction of lumbosacral myelomeningocele in a fetus with Chiari II malformation. Childs Nerv Syst. 2015; (4): 511-3.

Philpott CM, Shannon P, Chitayat D, Ryan G, Raybaud CA, Blaser SI. Diffusion-weighted imaging of the cerebellum in the fetus with Chiari II malformation. American Journal of Neuroradiology 2013; 34 (8): 1656-60.

Shrot S, Soares BP, Whitehead MT. Cerebral Diffusivity Changes in Fetuses with Chiari II Malformation. Fetal Diagn Ther. 2019; 45 (4): 268-274.

Krzesinski EI, Geerts L, Urban MF. Neural tube defect diagnosis and outcomes at a tertiary South African hospital with intensive case ascertainment. South African Medical Journal, 2019; 109 (9): 698-703.

Protzenko T, Bellas A, Pousa MS, Protzenko M, Fontes JM, de Lima Silveira AM, Sá CA, Pereira JP, Salomão RM, Salomão JF. Reviewing the prognostic factors in myelomeningocele. Neurosurgical Focus, 2019; 47 (4): E2.

Ravindra VM, Aldave G, Weiner HL, Lee T, Belfort MA, Sanz-Cortes M, Espinoza J, Shamshirsaz AA, Nassr AA, Whitehead WE. Prenatal counseling for myelomeningocele in the era of fetal surgery: a shared decision-making approach. Journal of Neurosurgery: Pediatrics, 2020; 25 (6): 640-7.5.

Karakas C, Fidan E, Arya K, Webber T, Cracco JB. Frequency, Predictors, and Outcome of Seizures in Patients with Myelomeningocele: Single-Center Retrospective Cohort Study. Journal of Child Neurology, 2022; 37 (1): 80-8.






Original Articles